Novel potential mechanisms of acquired resistance to anti-EGFR monoclonal antibody (mAb) therapy detected in liquid biopsies (LBx) from patients (pts) with advanced colorectal cancer (CRC).

Bibliographic Details
Title: Novel potential mechanisms of acquired resistance to anti-EGFR monoclonal antibody (mAb) therapy detected in liquid biopsies (LBx) from patients (pts) with advanced colorectal cancer (CRC).
Authors: Parseghian, Christine Megerdichian, Lee, Jessica Kim, Quintanilha, Julia, Schrock, Alexa B., Graf, Ryon, Pasquina, Lincoln, Sivakumar, Smruthy, Oxnard, Geoffrey R., Tukachinsky, Hanna, Klempner, Samuel J., Kopetz, Scott
Source: Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p199-199, 235p
Database: Supplemental Index
More Details
ISSN:0732183X
DOI:10.1200/JCO.2024.42.3_suppl.199
Published in:Journal of Clinical Oncology
Language:English